Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
100%
Adult Congenital Heart Disease
74%
Acute Decompensated Heart Failure
56%
Mechanical Circulatory Support
44%
United States
37%
Under 40
37%
International Index of Erectile Function
37%
Etiology
37%
Approaches to Management
37%
End-stage Heart Failure
37%
Preeclampsia
37%
Ventricular Assist Device
37%
Chemotherapy
37%
Cor Triatriatum Sinister
37%
Erectile Function
37%
Heart Function
37%
Ethical Considerations
37%
Elderly People
37%
Cardiomyopathy
37%
Aging Population
37%
Heart Transplantation
37%
Congenital Heart Disease
28%
Heart Failure Treatment
24%
Cardiac Transplantation
22%
Mitral
21%
Physical Activity
21%
Definitive Treatment
18%
Medical Treatment
18%
Cholecystectomy
18%
Donor Heart
18%
Heterogeneous Groups
18%
High Mortality
18%
Recurring
18%
Centers for Disease Control
18%
Device Therapy
18%
New York Heart Association Class
18%
High Morbidity
18%
Transplant Recipients
18%
Orthotopic Heart Transplantation
18%
Mechanical Circulatory Support Devices
18%
Acquired Heart Disease
15%
Elderly Patients
15%
Genetic Polymorphism
15%
Device Implantation
14%
Sudden Cardiac Death
14%
End-of-life Decisions
12%
21st Century
12%
Position Statement
12%
Cancer Therapy
12%
Failure Limits
12%
Medicine and Dentistry
Congestive Heart Failure
81%
Adult Congenital Heart Disease
74%
Persistent Truncus Arteriosus
52%
Ablation
37%
Postcholecystectomy Syndrome
37%
Myocardial Disease
37%
Elderly Population
37%
Atrial Fibrillation
37%
Eclampsia
37%
Ventricular Assist Device
37%
International Index of Erectile Function
37%
Heart Function
37%
Genetic Polymorphism
27%
Malignant Neoplasm
27%
Physical Activity
26%
Heart Disease
25%
Heart Transplantation
20%
Third Trimester Pregnancy
18%
Elderly Patient
15%
Atrial Fibrillation Ablation
14%
Heart Left Ventricle Failure
14%
Combination Therapy
12%
Sudden Cardiac Death
12%
Erectile Dysfunction
10%
Comorbidity
10%
Sedentary Lifestyle
10%
Diastolic Function
9%
Transthoracic Echocardiography
9%
Pre-Eclampsia
9%
In Silico
9%
Surgical Technique
7%
Cardiotoxicity
7%
Pathophysiology
7%
Terminal Illness
7%
Cardiovascular Condition
7%
Beneficence
7%
Survival Rate
7%
Cardiovascular System
7%
Antiinfective Agent
7%
Cancer Survival
7%
Quality of Life
7%
Treatment Duration
7%
Hospital Mortality
7%
Mortality Rate
7%
Molecularly Targeted Therapy
7%
Cardiology
7%
Oncology
7%
Shared Decision Making
7%
Cancer Therapy
7%
Cancer
7%